[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-355907-105":59,"doc-detail-355907-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","ppp4c-a-potential-molecular-marker-and-therapeutic-target-in-thyroid-cancer-and-triple-negative-breast-cancer","PPP4C - a potential molecular marker and therapeutic target in thyroid cancer and triple-negative breast cancer","","Protein phosphatase PPP4C has been implicated in oncogenic processes, yet its roles in thyroid carcinoma (THCA) and triple-negative breast cancer (TNBC) are not well defined. The study integrates bioinformatic analyses with in vitro experiments to assess clinical relevance and function. PPP4C is markedly upregulated in both cancers, correlating with adverse features and poorer survival. Knockdown reduces proliferation, migration, and invasion, linking PPP4C to oncogenic signaling and drug sensitivity while suggesting biomarker and therapeutic target potential.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/ppp4c-a-potential-molecular-marker-and-therapeutic-target-in-thyroid-cancer-and-triple-negative-breast-cancer/355907/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/ppp4c-a-potential-molecular-marker-and-therapeutic-target-in-thyroid-cancer-and-triple-negative-breast-cancer/355907.png","ImageObject",300,407,{"name":92,"@type":93},"Elsa","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What question does the paper address about PPP4C in THCA and TNBC?","Question",{"text":112,"@type":113},"It evaluates whether PPP4C has clinical and functional significance in thyroid carcinoma and triple-negative breast cancer, and whether it can serve as a molecular marker and therapeutic target.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How does PPP4C expression relate to patient outcomes in THCA and TNBC?",{"text":117,"@type":113},"PPP4C is significantly upregulated in tumor tissues versus normal tissues, and higher expression is associated with worse clinicopathological features and poorer overall survival.",{"name":119,"@type":110,"acceptedAnswer":120},"What do PPP4C knockdown experiments show about cancer cell behavior?",{"text":121,"@type":113},"PPP4C depletion suppresses proliferation, migration, and invasion in TNBC and THCA cell lines, supporting a pro-tumorigenic role in vitro.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},355907,1790514719,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":26,"preview_page_count":19,"preview_urls":145},137455077381,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Li etal. BMC Cancer (2026) 26:768 BMC Cancer  \n[https://doi.org/10.1186/s12885-026-16083-2](https://doi.org/10.1186/s12885-026-16083-2)  \nRESEARCH Open Access  \nPPP4C: a potential molecular marker and therapeutic target in thyroid cancer and triple-negative breast cancer  \nHuashui Li1,2†, Yifan Chen1,3†, Guodong Guo4†, Qinghua Luo5, Qiang Lin2, Wenjun Xie1,2* and Maolin Yan1,6*  \nAbstract  \nThe protein phosphatase PPP4C has been implicated in oncogenic processes, but its role in thyroid carcinoma (THCA) and triple-negative breast cancer (TNBC) remains unclear. Here, we combined bioinformatic analyses within vitro experiments to investigate the clinical and functional significance of PPP4C in these malignancies. PPP4C was significantly upregulated in both THCA and TNBC compared with normal tissues, and higher expression was associated with adverse clinicopathological features and poorer overall survival. Functional assays showed that PPP4C knockdown suppressed proliferation, migration, and invasion in TNBC and THCA cell lines, supporting a pro-tumorigenic role in vitro. Integrative analyses further suggested that elevated PPP4C expression is associated with oncogenic signaling pathways, RNA modification–related genes, and immune-related characteristics. Drug sensitivity prediction analysis indicated differential responsiveness to selected targeted agents, and experimental validation demonstrated that PPP4C depletion enhances sensitivity to specific inhibitors in vitro. Overall, PPP4Cis consistently overexpressed and functionally relevant in THCA and TNBC. PPP4C may represent a candidate biomarker associated with tumor progression and therapeutic response, warranting further mechanistic and in vivo investigation.  \nKeywords PPP4C, Thyroid cancer, Triple-negative breast cancer, Biomarker, Targeted therapy, Drug sensitivity  \n†Huashui Li, Yifan Chen and Guodong Guo contributed equally to this work.  \n*Correspondence: Wenjun Xie [xiewenjun89@163.com](xiewenjun89@163.com)[ ](xiewenjun89@163.com)Maolin Yan [yanmaolin74@163.com](yanmaolin74@163.com)  \n1Shengli Clinical Medical College of Fujian Medical University, Fuzhou, Fujian 350001, People’s Republic of China  \n2Department of Thyroid & Hernia Surgery, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian  \n350001, People’s Republic of China  \n3Department of Breast Surgery, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian 350001, People’s Republic of China 4Department of Pathology, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian 350001, People’s Republic of China 5Department of Pharmacy, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian 350001, People’s Republic of China 6Department of Hepatobiliary Pancreatic Surgery, Shengli Clinical Medical College of Fujian Medical University, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian  \n350001, People’s Republic of China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless i","cbCaiuEWEjboRup1","https://ap.wps.com/l/cbCaiuEWEjboRup1","pdf",15729922,24,"English","# Introduction\n## Background on breast cancer and TNBC\n## Bidirectional association between breast cancer and thyroid cancer","[{\"question\":\"What question does the paper address about PPP4C in THCA and TNBC?\",\"answer\":\"It evaluates whether PPP4C has clinical and functional significance in thyroid carcinoma and triple-negative breast cancer, and whether it can serve as a molecular marker and therapeutic target.\"},{\"question\":\"How does PPP4C expression relate to patient outcomes in THCA and TNBC?\",\"answer\":\"PPP4C is significantly upregulated in tumor tissues versus normal tissues, and higher expression is associated with worse clinicopathological features and poorer overall survival.\"},{\"question\":\"What do PPP4C knockdown experiments show about cancer cell behavior?\",\"answer\":\"PPP4C depletion suppresses proliferation, migration, and invasion in TNBC and THCA cell lines, supporting a pro-tumorigenic role in vitro.\"}]","PPP4C - a potential molecular marker and therapeutic target in thyroid cancer and triple-negative breast cancer | PDF",1790121670,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f0cc9e7b46aeb898fdbb2d4c21795fc8.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/b1b79290090c2ba893eb6af693ee37f9.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/248b5e8b8b849eb794cddee69d2d1020.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a5b828c97fbd10ade293079f221cac1b.webp",980,1306]